nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium Tetradecyl Sulfate—Extravasation—Carboplatin—bone cancer	0.142	0.183	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Cisplatin—bone cancer	0.0464	0.0597	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Cisplatin—bone cancer	0.0418	0.0537	CcSEcCtD
Sodium Tetradecyl Sulfate—Orlistat—CYP3A4—bone cancer	0.0389	1	CrCbGaD
Sodium Tetradecyl Sulfate—Ulcer—Cisplatin—bone cancer	0.0385	0.0496	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Carboplatin—bone cancer	0.0379	0.0488	CcSEcCtD
Sodium Tetradecyl Sulfate—Local reaction—Epirubicin—bone cancer	0.0338	0.0435	CcSEcCtD
Sodium Tetradecyl Sulfate—Local reaction—Doxorubicin—bone cancer	0.0313	0.0402	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Methotrexate—bone cancer	0.0255	0.0328	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Epirubicin—bone cancer	0.0239	0.0307	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Methotrexate—bone cancer	0.0229	0.0295	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Doxorubicin—bone cancer	0.0221	0.0284	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Epirubicin—bone cancer	0.0215	0.0276	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Methotrexate—bone cancer	0.0212	0.0272	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Methotrexate—bone cancer	0.02	0.0257	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Doxorubicin—bone cancer	0.0199	0.0255	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Epirubicin—bone cancer	0.0198	0.0255	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Epirubicin—bone cancer	0.0187	0.0241	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Doxorubicin—bone cancer	0.0183	0.0236	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Beta2 integrin cell surface interactions—PLAU—bone cancer	0.0179	0.0976	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Post-translational protein modification—MOGS—bone cancer	0.0176	0.096	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Doxorubicin—bone cancer	0.0173	0.0223	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Post-translational protein modification—MOGS—bone cancer	0.0156	0.0849	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Cisplatin—bone cancer	0.013	0.0167	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet degranulation—SPARC—bone cancer	0.0129	0.0705	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.0123	0.0672	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Pain—Cisplatin—bone cancer	0.0111	0.0143	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Complement and Coagulation Cascades—PLAU—bone cancer	0.0101	0.0553	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Cisplatin—bone cancer	0.00958	0.0123	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Complement and Coagulation Cascades—PLAU—bone cancer	0.00898	0.0489	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—MOGS—bone cancer	0.00835	0.0455	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Cisplatin—bone cancer	0.00827	0.0106	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Cisplatin—bone cancer	0.00773	0.00993	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—MOGS—bone cancer	0.00739	0.0403	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Methotrexate—bone cancer	0.00714	0.00918	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Epirubicin—bone cancer	0.00668	0.00859	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Doxorubicin—bone cancer	0.00618	0.00795	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Methotrexate—bone cancer	0.0061	0.00785	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.00574	0.0313	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Pain—Epirubicin—bone cancer	0.00571	0.00734	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Methotrexate—bone cancer	0.00567	0.00729	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Epirubicin—bone cancer	0.00531	0.00682	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Doxorubicin—bone cancer	0.00529	0.0068	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Methotrexate—bone cancer	0.00526	0.00676	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.00525	0.0286	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Epirubicin—bone cancer	0.00492	0.00633	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Doxorubicin—bone cancer	0.00491	0.00631	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—IL3—bone cancer	0.00476	0.0259	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—TUBB4B—bone cancer	0.00458	0.0249	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Doxorubicin—bone cancer	0.00455	0.00586	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Methotrexate—bone cancer	0.00454	0.00584	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Methotrexate—bone cancer	0.00447	0.00575	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Epirubicin—bone cancer	0.00425	0.00546	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Methotrexate—bone cancer	0.00424	0.00545	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Epirubicin—bone cancer	0.00418	0.00538	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—TUBB4B—bone cancer	0.00405	0.0221	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Epirubicin—bone cancer	0.00397	0.0051	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—TUBB2A—bone cancer	0.00395	0.0215	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Doxorubicin—bone cancer	0.00393	0.00505	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Doxorubicin—bone cancer	0.00387	0.00498	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Doxorubicin—bone cancer	0.00367	0.00472	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—TUBB2A—bone cancer	0.0035	0.0191	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—SPARC—bone cancer	0.00334	0.0182	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—GNA11—bone cancer	0.00306	0.0167	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—SPARC—bone cancer	0.00296	0.0161	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—IL3—bone cancer	0.00277	0.0151	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—EIF2S1—bone cancer	0.00276	0.015	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—GNA11—bone cancer	0.0027	0.0147	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—IL3—bone cancer	0.00245	0.0134	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—EIF2S1—bone cancer	0.00244	0.0133	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—ATF1—bone cancer	0.00226	0.0123	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—PLAU—bone cancer	0.00182	0.00991	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—PLAU—bone cancer	0.00161	0.00877	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—ATF1—bone cancer	0.00132	0.00719	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—KIT—bone cancer	0.00129	0.00702	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IL3—bone cancer	0.00129	0.00701	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—MMP2—bone cancer	0.00113	0.00614	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—MDM2—bone cancer	0.00101	0.00553	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—MMP2—bone cancer	0.000998	0.00544	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—JUN—bone cancer	0.000882	0.00481	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—KIT—bone cancer	0.00075	0.00409	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—TP53—bone cancer	0.000731	0.00398	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—EGFR—bone cancer	0.000693	0.00378	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—TP53—bone cancer	0.000647	0.00353	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—MDM2—bone cancer	0.000591	0.00322	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—JUN—bone cancer	0.000514	0.0028	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—EGFR—bone cancer	0.000404	0.0022	CbGpPWpGaD
